AB Deisseroth

4.1k total citations
69 papers, 3.0k citations indexed

About

AB Deisseroth is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, AB Deisseroth has authored 69 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 22 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in AB Deisseroth's work include Chronic Myeloid Leukemia Treatments (16 papers), Acute Myeloid Leukemia Research (15 papers) and Hematopoietic Stem Cell Transplantation (14 papers). AB Deisseroth is often cited by papers focused on Chronic Myeloid Leukemia Treatments (16 papers), Acute Myeloid Leukemia Research (15 papers) and Hematopoietic Stem Cell Transplantation (14 papers). AB Deisseroth collaborates with scholars based in United States, Canada and India. AB Deisseroth's co-authors include YO Huh, CL Reading, FR Appelbaum, Moshe Talpaz, Donna Przepiorka, Koen van Besien, Börje S. Andersson, David F. Claxton, Sergio Giralt and David Seong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

AB Deisseroth

65 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AB Deisseroth United States 33 2.0k 838 683 682 523 69 3.0k
GL Phillips Canada 25 1.8k 0.9× 1.1k 1.3× 524 0.8× 540 0.8× 575 1.1× 56 3.0k
Luc Douay France 35 1.9k 1.0× 747 0.9× 1.1k 1.6× 1.4k 2.0× 612 1.2× 143 4.4k
K Lilleby United States 24 2.8k 1.4× 1.6k 1.9× 639 0.9× 332 0.5× 840 1.6× 38 3.7k
P Hervé France 28 1.5k 0.8× 528 0.6× 478 0.7× 333 0.5× 631 1.2× 133 2.5k
RE Champlin United States 28 2.7k 1.3× 1.0k 1.2× 869 1.3× 407 0.6× 912 1.7× 50 3.4k
DC Arthur United States 25 1.6k 0.8× 953 1.1× 516 0.8× 754 1.1× 512 1.0× 47 3.0k
FR Appelbaum United States 17 1.9k 0.9× 647 0.8× 571 0.8× 249 0.4× 384 0.7× 19 2.4k
W. Heit Germany 25 1.3k 0.6× 469 0.6× 491 0.7× 597 0.9× 574 1.1× 95 2.3k
R Storb United States 25 2.6k 1.3× 833 1.0× 602 0.9× 260 0.4× 791 1.5× 47 3.3k
John A. Liu Yin United Kingdom 20 2.1k 1.0× 650 0.8× 523 0.8× 833 1.2× 374 0.7× 43 2.7k

Countries citing papers authored by AB Deisseroth

Since Specialization
Citations

This map shows the geographic impact of AB Deisseroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AB Deisseroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AB Deisseroth more than expected).

Fields of papers citing papers by AB Deisseroth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AB Deisseroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AB Deisseroth. The network helps show where AB Deisseroth may publish in the future.

Co-authorship network of co-authors of AB Deisseroth

This figure shows the co-authorship network connecting the top 25 collaborators of AB Deisseroth. A scholar is included among the top collaborators of AB Deisseroth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AB Deisseroth. AB Deisseroth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Guiying, W. Liu, John Mendelsohn, et al.. (1997). Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. JNCI Journal of the National Cancer Institute. 89(17). 1271–1276. 64 indexed citations
2.
Hanania, Elie G., Richard E. Giles, J. J. Kavanagh, et al.. (1996). The human multiple drug resistance gene (mdr-1) is used to confer chemoprotection upon hematopoietic progenitor cells in a clinical gene therapy trial setting for ovarian and breast cancer treatment. Journal of Investigative Medicine. 44(3). 1 indexed citations
3.
Seong, David, J. M. Bruner, Nadeem Q. Mirza, et al.. (1996). Progressive Multifocal Leukoencephalopathy After Autologous Bone Marrow Transplantation in a Patient with Chronic Myelogenous Leukemia. Clinical Infectious Diseases. 23(2). 402–403. 19 indexed citations
4.
Przepiorka, Donna, Cindy Ippoliti, Issa F. Khouri, et al.. (1996). Tacrolimus and minidose methotrexate for prevention of acute graft- versus-host disease after matched unrelated donor marrow transplantation. Blood. 88(11). 4383–4389. 101 indexed citations
5.
6.
Deisseroth, AB, et al.. (1995). Human embryonic zeta-globin gene expression in mouse-human hybrid erythroid cell lines. Blood. 86(3). 1212–1217. 2 indexed citations
7.
8.
9.
Zhang, W, M Beran, TL Smith, et al.. (1994). Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood. 84(1). 256–261. 60 indexed citations
10.
Claxton, David F., Paula Marlton, J Hester, et al.. (1994). Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood. 83(7). 1750–1756. 8 indexed citations
11.
Deisseroth, AB, et al.. (1994). Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia [see comments]. Blood. 84(2). 601–607. 48 indexed citations
12.
Reading, CL, EH Estey, YO Huh, et al.. (1993). Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood. 81(11). 3083–3090. 139 indexed citations
13.
Kantarjian, H., Moshe Talpaz, Dimitrios P. Kontoyiannis, et al.. (1992). Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.. Journal of Clinical Oncology. 10(3). 398–405. 58 indexed citations
14.
Guba, Susan C., Andrew P. Feinberg, Moshe Talpaz, et al.. (1991). Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells.. Journal of Clinical Investigation. 88(6). 2131–2136. 73 indexed citations
15.
LeMaistre, A, MS Lee, Moshe Talpaz, et al.. (1989). Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia. Blood. 73(4). 889–891. 55 indexed citations
16.
Glaubiger, Daniel, et al.. (1980). Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells: a case report. Blood. 56(3). 516–520. 79 indexed citations
17.
Deisseroth, AB, et al.. (1979). Autologous stem cell reconstitution and the intensive therapy of resistant solid tumors in man.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7 Suppl 5. 347–50. 1 indexed citations
18.
Wright, DG, et al.. (1978). Pretreatment of filtration leukapheresis donors with colchicine. Blood. 52(4). 783–792. 9 indexed citations
19.
Appelbaum, FR, et al.. (1978). Granulocyte transfusion therapy of experimental Pseudomonas septicemia: study of cell dose and collection technique. Blood. 52(2). 323–331. 44 indexed citations
20.
Appelbaum, FR, et al.. (1978). Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood. 52(1). 85–95. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by GL Phillips Breakdown of academic impact, for papers by Luc Douay Breakdown of academic impact, for papers by K Lilleby Breakdown of academic impact, for papers by P Hervé Breakdown of academic impact, for papers by RE Champlin Breakdown of academic impact, for papers by DC Arthur Breakdown of academic impact, for papers by FR Appelbaum Breakdown of academic impact, for papers by W. Heit Breakdown of academic impact, for papers by R Storb Breakdown of academic impact, for papers by John A. Liu Yin
Rankless by CCL
2026